Comparison of the sensitivity of culture, PCR and quantitative real-time PCR for the detection of Pseudomonas aeruginosa in sputum of cystic fibrosis patients by Deschaght, Pieter et al.
BioMed  Central
Page 1 of 7
(page number not for citation purposes)
BMC Microbiology
Open Access Methodology article
Comparison of the sensitivity of culture, PCR and quantitative 
real-time PCR for the detection of Pseudomonas aeruginosa in 
sputum of cystic fibrosis patients
Pieter Deschaght1, Thierry De Baere1, Leen Van Simaey1, Sabine Van daele2, 
Frans De Baets2, Daniel De Vos3, Jean-Paul Pirnay3 and 
Mario Vaneechoutte*1
Address: 1Laboratory for Bacteriology Research (LBR), Ghent University Hospital, University of Ghent, Ghent, Belgium, 2Cystic Fibrosis Centre, 
Department Pediatric Pulmonology, Ghent University Hospital, University of Ghent, Ghent, Belgium and 3Laboratory for Molecular and Cellular 
Technology (LabMCT), Burn Wound Center, Queen Astrid Military Hospital, Brussels, Belgium
Email: Pieter Deschaght - deschaght.pieter@ugent.be; Thierry De Baere - Thierry.DeBaere@iph.fgov.be; Leen Van 
Simaey - Leen.Vansimaey@ugent.be; Sabine Van daele - Sabine.Vandaele@ugent.be; Frans De Baets - Frans.DeBaets@ugent.be; Daniel De 
Vos - Daniel.DeVos2@mil.be; Jean-Paul Pirnay - Jean-Paul.Pirnay@mil.be; Mario Vaneechoutte* - Mario.Vaneechoutte@ugent.be
* Corresponding author    
Abstract
Background:  Pseudomonas aeruginosa is the major pathogen involved in the decline of lung
function in cystic fibrosis (CF) patients. Early aggressive antibiotic therapy has been shown to be
effective in preventing chronic colonization. Therefore, early detection is important and sensitive
detection methods are warranted. In this study, we used a dilution series of P. aeruginosa positive
sputa, diluted in a pool of P. aeruginosa negative sputa, all from CF patients - to mimick as closely
as possible the sputa sent to routine laboratories - to compare the sensitivity of three culture
techniques versus that of two conventional PCR formats and four real-time PCR formats, each
targeting the P. aeruginosa oprL gene. In addition, we compared five DNA-extraction protocols.
Results: In our hands, all three culture methods and the bioMérieux easyMAG Nuclisens protocol
Generic 2.0.1, preceded by proteinase K pretreatment and followed by any of the 3 real-time PCR
formats with probes were most sensitive and able to detect P. aeruginosa up to 50 cfu/ml, i.e. the
theoretical minimum of one cell per PCR mixture, when taking into account the volumes used in
this study of sample for DNA-extraction, of DNA-elution and of DNA-extract in the PCR mixture.
Conclusion: In this study, no difference in sensitivity could be found for the detection of P.
aeruginosa from sputum between microbiological culture and optimized DNA-extraction and real-
time PCR. The results also indicate the importance of the optimization of the DNA-extraction
protocol and the PCR format.
Background
Patients with cystic fibrosis (CF), an autosomal recessively
inherited disease caused by a mutation in the Cystic Fibro-
sis Transmembrane Conductance Regulator (CFTR) gene,
are particularly susceptible to pulmonary infections with
Pseudomonas aeruginosa [1,2]. Colonization of the airways
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of CF patients with P. aeruginosa results in higher morbid-
ity and mortality because of the faster decline of the lung
function, especially from the chronic infection phase
onwards [3-5]. Detection of colonization and infection by
this pathogen as early as possible enables to postpone the
chronic infective stage and eventually to achieve the erad-
ication of P. aeruginosa through early treatment. Indeed,
early aggressive antibiotic therapy is now generally
accepted as an efficient means to postpone chronic colo-
nization [6,7].
In most routine laboratories detection of bacterial species
in respiratory samples is achieved by culture. However, it
has been shown that routine culture of sputa from CF
patients yields limited microbiological information since
it frequently fails to identify the pathogens, which were
shown to be present by means of PCR [8]. Furthermore,
the correct detection and identification of P. aeruginosa,
although in general not a fastidious organism, is not as
straightforward as frequently assumed [9,10]. To circum-
vent culture associated limitations, several molecular
assays for the detection of Pseudomonas species have been
described [8,11-19], Döring and colleagues [20] correctly
remarked that, because of the influence of sample pre-
treatment, DNA-extraction protocol and the PCR format,
there is a need for validation of the PCR techniques before
these can be used in a routine laboratory. However, to our
knowledge, no study systematically compared the sensi-
tivity of different culture, DNA-extraction, PCR and real-
time PCR methods for the detection of P. aeruginosa from
CF sputum, by using a CF patient sputum based dilution
series of P. aeruginosa.
Here, we compared the sensitivity of three culture media,
five DNA-extraction protocols, two conventional PCR for-
mats and four real-time PCR formats for the detection of
P. aeruginosa, using a dilution series of P. aeruginosa posi-
tive sputa in a pool of P. aeruginosa negative sputa.
Results
In this study, we compared the sensitivity of different cul-
ture and PCR methods. To that purpose, we prepared a P.
aeruginosa dilution series in CF sputum by diluting P. aer-
uginosa positive CF patient sputa in a pool of P. aeruginosa
negative CF patient sputa. This was done instead of dilut-
ing cultured P. aeruginosa cells in saline or diluting P. aer-
uginosa positive sputum in saline or spiking sputa with P.
aeruginosa cells, to mimick as closely as possible the spu-
tum samples sent to routine laboratories.
Comparison of culture methods
No differences in detection limit could be observed
between McConjey Agar (MCA) and Cetrimide Agar (CA),
i.e. respectively an average of 2 and 3 colonies were
counted at dilution eight. For Cetrimide Broth (CB) the
detection range was also comparable with that of MCA
and CA, i.e. P. aeruginosa could be detected up to dilution
eight, but the number of colonies was too high to be
countable (Table 1).
Based on these results, the number of culturable cells in
the original sputum preparation was calculated to be 1.6
log8 cfu/ml.
Comparison of DNA-extraction protocols
For each sputum dilution, DNA was extracted by four pro-
tocols using the bioMérieux easyMAG Nuclisens semi-
automated DNA-extractor and by the protocol for the
manual High Pure PCR Template Preparation Kit (Roche).
Results are listed in Table 1. In our hands, the BioMérieux
easyMAG Nuclisens protocol Generic 2.0.1, combined
with proteinase K pretreatment, was the DNA-extraction
protocol that enabled the most sensitive detection of P.
aeruginosa from sputum of CF patients, both with conven-
tional and with qualitative PCR, giving amplification of
the P. aeruginosa oprL target gene up to dilutions 6 and 8,
respectively. This DNA-extraction protocol was used fur-
ther to compare a total of two different conventional PCR
and four different (quantitative) real-time PCR formats.
Comparison of different PCR and real-time PCR formats
Conventional PCR, using the Veriti 96-Well Thermal
Cycler (Applied Biosystems), combined with visualisation
of the PCR products by agarose gel electrophoresis and
ethidium bromide staining respectively by capillary elec-
trophoresis and fluorescence measurement, was com-
pared with three different real-time PCR formats using the
LightCycler 1.5 (Roche) and with a commercially availa-
ble P. aeruginosa specific real-time PCR (TaqMan assay)
using the ABI7000 (Applied Biosystems). One real-time
PCR format used SybrGreen fluorescence as the detection
method, whereas the other three real-time PCR formats
relied on the fluorescence generated by probes for detec-
tion.
Results are listed in Table 2. For the conventional PCR,
combined with agarose gel electrophoresis, P. aeruginosa
DNA could be detected up to dilution 6, while with capil-
lary electrophoresis amplified P. aeruginosa DNA could be
detected up to dilution 7. P. aeruginosa DNA could be
detected up to dilution 7 with real-time PCR using
SybrGreen, and up to dilution 8 with real-time PCR with
the Hybprobes, with the TaqMan probe and with the com-
mercial Pseudomonas aeruginosa TaqMan probe detection
kit on the ABI7000. In conclusion, the three probe based
real-time PCR formats were the most sensitive molecular
assays.
Discussion
Pseudomonas aeruginosa is the major pathogen in cystic
fibrosis (CF) patients and is an indicator of poor progno-
sis in CF patients, especially from the onset of the chronicBMC Microbiology 2009, 9:244 http://www.biomedcentral.com/1471-2180/9/244
Page 3 of 7
(page number not for citation purposes)
Table 1: Comparison of the sensitivity of different DNA-extraction protocols as assessed by means of conventional PCR combined 
with agarose gel electrophoresis and by real-time PCR on LightCycler using TaqMan probe
Molecular detection
Extraction Protocol Pretreatment Last positive dilution
PCRa Real-timeb
easyMAG Generic 2.0.1 Proteinase K 6 8
easyMAG Generic 2.0.1 None 5 7
easyMAG Specific B Proteinase K 5 7
easyMAG Specific B None 5 7
High Pure Manual Proteinase K 5 6
Detection by culture
McConkey Agar (MCA) 8c
Cetrimide Agar (CA) 8c
Cetrimide Broth with subculture on Blood Agar (CB) 8
a Conventional PCR with primers PAO1 S and PAO1 A using the Veriti 96-Well Thermal Cycler.
b Real-time PCR with primers PAO1 S and PAO1 A and TaqMan probe oprL TM using the LightCycler 1.5.
c The initial inoculum was calculated by averaging the number of cfu at dilution 8 on MC and CA, i.e. 2.5 cfu/50 μl, multiplying with 20 to obtain the 
cfu/ml, i.e. 50 cfu/ml, multiplying with the dilution factor 1/3125000 to obtain the initial inoculum after dilution with Sputasol, i.e. 78 125 000 cfu/ml, 
and finally multiplying with factor 2 to obtain the original number of cfu/ml of sputum, i.e. 156 250 000 cfu/ml, or approx. 1.6 log8 cfu/ml.
Table 2: Comparison of the sensitivity of the different PCR formats for sputum dilutions extracted with easyMAG Generic 2.0.1 and 
proteinase K pretreatment
PCR formata Cyclerc Primers Probes Annealing temperature 
(°C)d
Last positive dilution
1. PCR + AGEb 1P A O 1  S / P A O 1  A N o n e 5 5 6
2. PCR + FCE 1 PAO1 S/PAO1 A None 55 7
3. real-time PCR + SybrGreen 2 PAO1 S/PAO1 A None 55 7
4. real-time PCR + HybProbes 2 oprL F/oprL R oprL-LC-ROX/oprL-LC-FAM 57 8
5. real-time PCR + TaqMan 
probeb
2P A O 1  S / P A O 1  A oprL TM 55 8
6. real-time PCR + TaqMan 
probe
3 Not specified Not specified 60 8
a AGE: Agarose gel electrophoresis + ethidium bromide staining; FCE: Fluorescent capillary electrophoresis on ABI310.
b PCR formats that were used to compare the sensitivity of the different DNA-extraction protocols (Table 1).
c 1: Veriti 96-Well Thermal Cycler, Applied BioSystems, Foster City, Ca.; 2: LightCycler 1.5, Roche, Basel, Switzerland; 3: ABI Prism 7000 Sequence 
Detection System, Applied BioSystems.
d Annealing temperatures as specified by provider of primers and probes (PCR formats 1-5) or by provider of commercial kit (PCR format 6).BMC Microbiology 2009, 9:244 http://www.biomedcentral.com/1471-2180/9/244
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stage when colonies become mucoid and variant pheno-
types emerge. Early detection is essential given the success
of early aggressive eradication therapy [6,7]. Therefore,
the most prevalent detection and identification methods,
i.e. culture and (real-time) PCR, should be optimized to
achieve the highest sensitivity.
West et al. [21] reported that specific P. aeruginosa anti-
bodies were detectable between 6 and 12 months prior to
the first positive culture for P. aeruginosa from respiratory
samples. These findings suggest that culture may miss P.
aeruginosa in the early stages of colonization. Also at later
stages, culture can miss the emerging P. aeruginosa pheno-
typic variants such as the pyoverdine negative mutants,
the slowly growing variants, the small colony variants and
the auxotrophs, which do not grow on standard media
[9,10]. Therefore, the development of improved culture
methods and/or of molecular methods is warranted, not
only for early detection but also for follow up of colo-
nized patients. However, although several molecular
assays for the detection of Pseudomonas species have been
described (e.g., [11,13-19,22-26]), surprisingly few stud-
ies have compared selective and nonselective culture
methods with the different molecular methods that have
been described for the detection of P. aeruginosa directly
from clinical samples.
The studies comparing sensitivity of culture and species-
specific PCR for the detection of P. aeruginosa from sputa
of CF patients indicate comparable efficiency of both
methods [8,16], with slightly higher sensitivity for PCR in
some studies [12,18] or clearly higher sensitivity for PCR
[13,26]. We used the PCR format published by De Vos et
al. [13] in combination with optimized DNA-extraction
methods and used in addition real-time PCR to increase
PCR sensitivity further. However, using a sputum dilution
series of P. aeruginosa, and in accordance to most studies,
we found no difference in sensitivity between any of the
three culture methods and the most sensitive molecular
method, i.e. DNA-extraction with easyMAG protocol
Generic 2.0.1 and proteinase K pretreatment combined
with any of the three probe-based real-time PCRs. In our
hands, culture was more sensitive than PCR and
SybrGreen based real-time PCR and the difference was
even more pronounced when not optimal DNA-extrac-
tion methods were used. It should be noticed that we
found no difference between selective and nonselective
culture methods, but this may be due to the fact that no
bacteria, other than P. aeruginosa in the two P. aeruginosa
positive patients, could be cultured from the sputa of the
8 CF patients. As shown in other studies and confirmed
here, the pretreatment of the sample and the DNA-extrac-
tion protocol strongly influence the sensitivity of the PCR
[27,28]. The most sensitive molecular detection method
was obtained using the easyMAG Generic 2.0.1 protocol
with proteinase K pretreatment in combination with real-
time PCR with the TaqMan probe or the HybProbes. Pre-
vious studies showed already that the easyMAG extractor
is one of the most sensitive and reliable methods for
DNA-extraction [29-31]. An additional advantage of auto-
mated DNA-extraction like easyMAG might be the lower
sample processing variability [28].
Because both approaches, i.e. culture and (real-time) PCR,
have important advantages as well as drawbacks
[14,20,32,33], in our opinion, both should be or can be
combined. PCR technology has the potential to detect the
fastidious P.aeruginosa variants, which are not detected by
the routinely used classical culture procedures [9,10],
whereas culture yields a complete genome that can be
used for e.g. phenotypic susceptibility testing and whole
genome based genotyping techniques like RAPD, PFGE
and AFLP [22]. Indeed, several of the published studies
indicate that there are instances of culture positive PCR
negative samples [11,12,15] as well as culture negative
PCR positive samples [11-13,18,19], whereby P. aerugi-
nosa infection can only be reliably demonstrated when
both approaches are combined.
Conclusion
In summary, we showed, by testing P. aeruginosa positive
sputum dilution series, that there is no difference in sen-
sitivity for the detection of P. aeruginosa in sputum by
selective and non-selective culture and by the most effi-
cient DNA-extraction method combined with the most
efficient real-time PCR formats, i.e. the probe-based ones.
A prospective study, whereby culture is compared with the
DNA-extraction/real-time PCR combination that was
established in this study as being the most sensitive, has
been started and should learn whether both approaches
also yield comparable results when used to detect low
inocula of P. aeruginosa as can be found after recent infec-
tion, in the sputum or nasopharyngeal samples of CF
patients not yet colonized by P. aeruginosa.
Methods
Culture and identification of bacteria
All 8 sputum samples used for this study were collected
from cystic fibrosis patients and were cultured on McCo-
nkey Agar (MCA) (Becton Dickinson, Cockeysville, MD)
and Cetrimide Agar (Cetrimide Broth (Fluka Biochemika,
Buchs, Switzerland) + 4% Bacto Agar (Becton Dickin-
son))(CA) to check for the presence of Pseudomonas aeru-
ginosa. The two sputum samples from the chronically
infected CF patients yielded only P. aeruginosa, as identi-
fied by tDNA-PCR and confirmed by OprL PCR [13,34-
37], whereas the six sputum samples from the not chron-
ically infected CF patients were culture and PCR negative
for P. aeruginosa, as tested in the routine laboratory and
confirmed by our laboratory.BMC Microbiology 2009, 9:244 http://www.biomedcentral.com/1471-2180/9/244
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Dilution series of P. aeruginosa positive sputum in P. 
aeruginosa negative sputum
All 8 sputa were liquefied by adding v/v Sputasol (Oxoid
Ltd, Poole, UK) and incubated during 1 hour at 37°C. The
two liquefied sputa from the CF patients positive for P.
aeruginosa were pooled and subsequently diluted tenfold
(for dilutions nr 1 and 2) and fivefold (for dilutions nr 3-
9) in a pool of liquefied sputa from the six CF patients
negative for P. aeruginosa. Written informed consent was
obtained from the patients for publication of this report.
Copies of the written consent are available for review by
the Editor-in-Chief of this journal.
Culture techniques
Fifty μl of each dilution was inoculated onto plates (MCA
or CA) or into cetrimide broth and incubated for 24 h at
37°C at ambient atmosphere. Cetrimide Broth was sub-
cultured by inoculating 50 μl onto a Blood Agar plate
(Becton Dickinson), which was incubated for 24 h at
37°C (CB). All dilution cultures were done in triplicate
and P. aeruginosa colonies were counted.
DNA-extraction protocols
A total of five different DNA-extraction protocols were car-
ried out on each sputum dilution. Two protocols, i.e.
Generic 2.0.1. and Specific B, whereby in the latter a dou-
ble concentration of silica is used and additional washing
steps are included, aiming at DNA-extraction from more
difficult samples, using the bioMérieux easyMAG Nucli-
sense extractor (bioMérieux, Marcy-l'Etoile, France), with
and without prior proteinase K treatment, were compared
with each other and with the manual High Pure PCR Tem-
plate Preparation Kit (Roche Applied Science, Basel, Swit-
zerland), carried out according to the manufacturer's
recommendations. Proteinase K pretreatment consisted of
incubation of 200 μl of each sputum dilution during 1 h
at 55°C in 200 μl proteinase K buffer (1 mg/ml proteinase
K, 0.5% SDS, 20 mM Tris-HCl, pH 8.3) with vortexing
every 15 min. For each extraction the start volume was
200 μl of liquefied sputum and the elution volume was 50
μl. Extracted DNA was stored at -20°C prior to PCR.
The quality of the DNA-extracts obtained with the 5 differ-
ent extraction protocols was compared by conventional
PCR, targeting the oprL gene with 0.5 μM of primers PAO1
S and PAO1 A in combination with agarose gel electro-
phoresis and ethidium bromide staining and by oprL real-
time PCR with 0.5 μM of primers PAO1 S and PAO1 A and
0.1 μM of TaqMan probe oprL TM (Table 3).
The DNA-extraction protocol, which enabled the most
sensitive detection as assessed by these two PCR formats,
was used to compare different PCR and real-time PCR for-
mats.
PCR and real-time PCR formats
Depending on the type of PCR, detection of P. aeruginosa
was done using two primer sets (Table 2 and Table 3).
Both primer sets are targeting the oprL gene because avail-
able sequences of different isolates show that this gene is
highly conserved http://www.pseudomonas.com/
related_links.jsp#alleles. A total of six PCR formats (incl.
4 real-time PCR formats) were compared.
Conventional PCR, using the Veriti 96-Well Thermal
Cycler (Applied Biosystems, Foster City, Ca.), was done
with primers PAO1 S (TET-labeled) and PAO1 A, whereby
PCR products were subsequently visualized either with
agarose gel electrophoresis and ethidium bromide stain-
ing or with fluorescent capillary electrophoresis. Agarose
gel electrophoresis was carried out at 100 V on an agarose
gel of 2.5% (w/v), containing 1 mg/ml ethidium bromide
and visualized on a UV transilluminator at 540 nm. For
Table 3: Sequences of primers and probes used
Primer/Probe 5'-3' Sequenced Amplicon size (bp) Reference or source
PAO1 Sa
PAO1 Aa
ACC CGA ACG CAG GCT ATG-TET
CAG GTC GGA GCT GTC GTA CTC
92 TIB Molbiol
oprL Fa
oprL Ra
ATG GAA ATG CTG AAA TTC GGC
CTT CTT CAG CTC GAC GCG ACG
504 [13,28]
oprL-LC-FAMb TGC GAT CAC CAC CTT CTA CTT CGA GT-FAM / TIB Molbiol
oprL-LC-ROXb ROX-CGA CAG CTC CGA CCT GAA G / TIB Molbiol
oprL TMc FAM-AGAAGGTGGTGATCGCACGCAGA-BBQ / TIB Molbiol
a Primers
b HybProbes
c TaqMan Probe.
d TET, FAM and ROX are fluorescent labels. BBQ: BlackBerry quencherBMC Microbiology 2009, 9:244 http://www.biomedcentral.com/1471-2180/9/244
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capillary electrophoresis, 1 μL of PCR product was added
to a mixture of 12 μL deionised formamide, 0.3 μL ROX-
labeled GS-400 high-density size standard and 0.2 μL
ROX labeled GS-500 size standard. This mixture was then
electrophoresed on an ABI PRISM 310 (Applied Biosys-
tems), as described previously [35].
Of the four real-time PCR formats, three were carried out
on the LightCycler 1.5 Instrument (Roche) using three dif-
ferent LightCycler real-time PCR kits, all with an opti-
mized MgCl2  concentration, i.e. LightCycler FastStart
DNA MasterPLUS SYBR Green I (Roche), LightCycler Fast-
Start DNA MasterPLUS HybProbe (Roche) and LightCycler
Taqman Master (Roche) and one was carried out on the
ABI7000 instrument, using the commercially available
TaqMan  Pseudomonas aeruginosa detection kit (Applied
Biosystems). For all of these PCR formats, the PCR mixes
were prepared as recommended by the manufacturer and
also the PCR programs were carried out as prescribed by
the manufacturer. For the conventional PCRs, the real-
time PCR on the LightCycler 1.5 with SYBR Green I and
with the TaqMan probe, the annealing temperature was
set to 55°C, while for the real-time PCR with the Hyb-
Probes the annealing temperature was set to 57°C, as
determined by the manufacturer of the primers and
probes (TIB Molbiol, Berlin, Germany). For the commer-
cially available TaqMan Pseudomonas aeruginosa detection
kit the annealing temperature was set to 60°C, according
to the manufacturers' instructions.
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